Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:17 AM
Ignite Modification Date:
2025-12-25 @ 2:17 AM
NCT ID:
NCT00418860
Eligibility Criteria:
Inclusion Criteria:
* Patients with clinically significant de novo coronary artery disease
* Stenting only with Endeavor® stents
* The sum of stent length is less than 60 mm for one lesion. The sum of stent length in multiple lesions does not matter.
Exclusion Criteria:
* Cardiogenic shock
* ST-elevation myocardial infarction within 48 hours of symptom onset
* Prior implantation of drug-eluting stents
* Left ventricular dysfunction (echocardiographic left ventricular ejection fraction \< 25%)
* Stenting both branch of bifurcation lesion
* Left main trunk lesion
* Graft vessels
* Patients who have to receive clopidogrel due to other conditions
* Patients who have to receive warfarin, cilostazol or other antiplatelet therapy
* Patient with chronic renal failure (S-Cr \> 2.0 mg/dl)
* Hypersensitivity to clopidogrel or aspirin
* Expectant survival less than 1 year
* Women who plan to become pregnant
* Patients with bleeding diathesis (coagulopathy, thrombocytopenia or platelet dysfunction, Gastrointestinal or genitourinary bleeding within the prior 3 months)
* Patients who are actively participating in another drug or device investigational study, which have not completed the primary endpoint follow-up period.
Healthy Volunteers:
False
Sex:
ALL
Study:
NCT00418860
Study Brief:
Protocol Section:
NCT00418860